JNJ Daily TimeframeSNIPER STRATEGY
This magical strategy works like a clock on almost any charts
Although I have to say it can’t predict pullbacks, so I do not suggest this strategy for leverage trading.
It will not give you the whole wave like any other strategy out there but it will give you huge part of the wave.
The best timeframe for this strategy is Daily, Weekly and Monthly however it can work any timeframe above three minutes.
Start believing in this strategy because it will reward believers with huge profit.
There is a lot more about this strategy.
It can predict and also it can give you almost exact buy or sell time on the spot.
I am developing it even more so stay tuned and start to follow me for more signals and forecasts.
Johnsonandjohnson
JNJ Will the $200 stop a protracted and non-corrective rally?Johnson & Johnson is a major manufacturer of cosmetic and sanitary products, as well as medical equipment and medicines. The company was founded in 1886.
In general, the history of the company is mega-successful. The corporation expanded through the purchases of competitors and gained more and more market share in its areas.
The company's progress is confirmed by the capitalization, which exceeds $430bn , as well as the graph of the JNJ share price, which is growing parabolic.
For 10 years, from 2002 to 2012, smart and patient investors recruited long positions in JNJ shares. During this period, the price traded in a broad consolidation of $46-71, growing volumes talked all - patience and everything will be)
From 2012 to the present, the value of JNJ shares has grown practically without correction.
Even during the Covid market plunge in February-March 2020, JNJ shares fell by only -29%. For example, then the S&P500 fell by -35%, the DJI index -38%, and the shares of the hype TSLA by as much as -60%.
The investors in this company knew and believed and they did not lose, because during the COVID-19 pandemic, a subsidiary of Johnson & Johnson, Janssen Pharmaceutica, developed a vaccine against this virus, which is certified for use in the USA and the EU, and the value of JNJ shares has renewed its absolute maximum.
Since the beginning of the year, JNJ's share price has been pushed towards the important $171 level . After the price fixes above this level, another upward impulse will take place.
We assume that it may be final before the start of a prolonged downward correction.
In the region of $195-200, it is better to fix the longs and look around, because the correction can be deep enough, and enough people who want to buy JNJ shares again may be in the $ 84-96 zone.
Johnson & Johnson should stick to baby wipes.....Vaccine Recall!With the news that the CDC is pausing J&J vaccine distribution due to blood clot issues.
I'm assuming we should see it tank at the open? You're guess is as good as mine.
In my opinion if we see price drop it should be a good time to buy, because everyone else is selling.
The level I'm interested in is $147-$150.
It is an untested point of control where institutions may have some buy orders sitting.
Watch for an ABCD on the line chart (close to close) for entry.
We may not break the 2021 high, but if the March equal highs remain untouched, I would look to enter because there is still possibly liquidity there.
$150 should give a nice reaction if we hit it while those highs are untouched.
Let's Elevate,
Gio
$JNJ may breakout soon.There is a great deal to be bullish about for JNJ. I anticipate the price will find a nice runup as the recent bullish volume along with strong institutional exposure (70%) leads me to believe we find the price moving higher. The other fascinating observation is the strong earnings growth with virtually no new sales growth. This is a company run incredibly well & lean touting a net margin of 21%.
I like the EMA. I like that on this pass the Bollinger's are much higher in avg price & the price tapped mean reversion and continued to rise. Chart of this below, and the final chart will display pivot points for those that care about locating the war zone of support & resistance.
I am a JNJ Bull Folks.
Johnson and Johnson drops again. NYSE:JNJ I can't look at a whole bunch of pharma stocks and just skip JnJ. For the uninitiated, this is the largest Pharmaceutical company in the world (by far) and a major, major player in the world of medical devices and OTC consumables as well. Anyway, down we go, and, not financial advice.
MARKET OVERVIEW 👨👩👧👦 | $SPY + $APPL + $JNJ + $JPM + $T📊📊📊Let's take a look at the S&P, Apple, Johnson and Johnson, and AT&T. Today we are looking to see if we can find the direction of the market going into the week by analyzing some top S&P holdings that are indicative of different key sectors.
The idea is to look at two bullish sector charts Apple (tech) and Johnson and Johnson (healthcare), and two bearish charts JP. Morgan (financials) and AT&T (communications), to see if we can find the direction of the market.
While our money is on more upside eventually (especially with Apple making an All-Time High (ATH), zero interest rates, and stimulus outweighing temporary slow recovery concerns), we want to know if the bears of the market pull us down or the bulls can sustain continued uptrend going into the week.
This write up took a long time so please Hit that 👍 button to show support for the content and help us grow 🐣
---
S&P 500 Index
Support S&P:
We have found a reaction on the S1 major price pivot point at the S/R flip. This is of course the ideal spot for the bulls to find support. If that last wick was the only test of this level we end up getting, all the better for the bulls.
If we do need to test lower levels, then the S2 untested bullish orderblock right below us provides another chance at retaining a bullish market structure.
If neither of these hold, the bulls have one last chance at the uptrend with the S3 orderblock cluster and previous range lows. A grind down to this level like we see with AT&T seems like one possible pathway there.
Resistance S&P:
The main resistance we will be looking at with most of these charts is seen in the S&P's R1 orderblock cluster at the previous swing high.
Regardless of where we find support, this resistance will be the main point of contention.
---
Apple
Support APPL:
Apple is by far the most bullish asset here. It is also the top holding of the S&P. The major support for Apple is the S1 orderblock and S/R flip cluster at the previous All-Time High. For the rest of the market to retain a bullish structure, S1 holding is key.
If S1 can't hold, the S2 orderblock and gap-fill is the next best hope for the bulls. The bulls don't want to see any weakness for Apple, so holding these levels and making new highs is key.
Resistance APPL:
Apple resembles the S&P, and that is logical because it is the biggest S&P holding. Rejection at R1 for Apple means no new ATH. Breaking R1 means a new ATH. How Apple reacts matters for the market. We see this one being broken eventually, but it has to happen sooner rather than later to lift the rest of the market up and avoid a "slow recovery."
---
Johnson & Johnson
Support JNJ:
The S1 orderblock and gap-fill on JNJ is about to be tested and is the ideal support. Finding support here means another point for the S&P bulls because we get JNJ working for us and not against us.
If S1 can't hold, we have S2 not too far away, this plays into the S&P's S2 holding as well. A dip this low isn't ideal, but the bullish market structure isn't broken if S2 holds.
Resistance JNJ:
JNJ has been correcting longer than most of the stocks on this chart. Of course, it also has a more bullish overall structure than our JPM and T bearish charts. For JNJ though, the longer correction means more levels of resistance, both the R1 S/R and orderblock and R2 S/R stand in the way for JNJ. This makes it a little harder to rely on than Apple from a pure TA perspective.
---
J.P. Morgan
Support JPM:
Big banks have their pros and cons right now, but for the market to reflect those pros S1 holding is ideal. JPM could be off to the races, or it could be making a drawn-out bottom formation.
A retest of S2 gives weight to that long drawn out bottom, therefore the big bank and S&P bulls want S1 to hold so we can maintain momentum.
Resistance JPM:
The primary resistance for J.P. Morgan is the R1 orderblock at the prior swing high. The recent market structure is similar to Apple and the S&P as a whole, it is only the previous structure that signals that JPM is a weaker asset currently. Some good JPM fundamentals could help the S&P here.
---
AT&T
Support T:
AT&T is the most bearish S&P holding we are charting. It lost its major support and is onto the S2 S/R and orderblock cluster. If this one doesn't hold, giving us a higher low, then we are simply retesting the COVID lows. If major holdings start breaking down to new lows, its a bad look for the market. The best way to avoid making new lows is not to retest old lows and instead to make lower highs. This is what the bulls want from T.
Resistance T:
Even though this is the most bearish chart, there isn't a ton of noteworthy resistance, which is a good thing. R1 is the main resistance for T. This range is notable as it was a previous resistance as well, T has this in common with the S&P... which helps confirm R1 being an important level to breach for the bulls.
---
Summary:
The S&P rallying from here or consolidating above S1 would be ideal for the bulls. For this, we need the more bullish S&P holdings like APPL and JNJ to hold their respective support levels and then rally while weaker holdings like JPM and AT&T avoid too much further correction.
If some of the weaker holdings can find support at their current ranges, or perhaps even at the next range down while the more bullish holdings stay their ground, then we could still be looking for S1 and S2 to hold for the S&P.
However, if the market tries to go bear, then we would more be looking big tech like Apple to hold up the rest of the market like Atlas while we eye S3 for support for the S&P.
It seems unlikely that we make new lows, and so we are looking for support to hold overall, but a trip down to S3 certainly will have an overall market recovery mimicking the slower recovery noted by the FED and this scenario likely results in retests of the bottom for some of the weaker S&P holdings.
Will the S&P pull an Apple and aim for new All-Time Highs, will it correct for a bit like JNJ perhaps taking us to S3, or are we going to get a JPM and T style upset? That is the question.
Resources:
www.zacks.com + www.nytimes.com
The Baby Powder Gives You Cancer! 😯 (JNJ)📈 Failed to breach through the highs, but the fight ain't over yet!
Downward channel identified. Seeing a lot of rejection at this channel top as we approach a critical level of support at 143.47.
You want to long when the downward black Resistance gets cracked. Otherwise short 143.47 break and see if the bottom channel support holds.
Critical to use the ema dots and the Crossover strategy at that 143.47 level for a more aggressive long if held.
Could be double top or could be cup and handle. 🤷♂️
Play the channel.
Best of luck! 🎲
🥇MLT | MAJOR LEAGUE TRADER
Johnson & Johnson Corrective Wave May End Soon!After the motive wave on JNJ, the stock is now going through some corrections. Now that the stock price is close to the lower part of the bullish wedge, any rejection with a strong bullish candlestick could cause the price to re-test its upper part...
N.B
- Let emotions and sentiments work for you
-ALWAYS Use Proper Risk Management In Your Trades
Johnson & Johnson Technical AnalysisWait Before buying - check if the support level will not be broken before buying, otherwise hold
Fundamental Analysis
Johnson & Johnson (NYSE:JNJ) began researching vaccine candidates in January, as soon as the COVID-19 sequence became available.
A Phase 1 clinical trial of the novel coronavirus vaccine is planned for September, with data regarding safety and efficacy available by the end of the year. If all goes accordingly, the vaccine could be ready “for emergency use” in early 2021.
As part of this commitment, Johnson & Johnson will scale up its manufacturing capacity in the U.S. and other countries in order to enable the supply of more than 1 billion doses of the vaccine when it is ready.
JOHNSON & JOHNSON (JNJ) Monthly, Weekly & DailyTrades made when the monthly, weekly and daily arrows are pointing in the same direction
are the most profitable.
For best results trade in the direction of the trend.
The Linear Regression channel is used to determine trend direction. The Linear Regression is set at 2 -2 30.
When a green Henikin Ashi candle intersects with the linear regression upper deviation line (green line) and both indicators intersect with a Djinn prediction date a sell is triggered.
When a red Henikin Ashi candle intersects with the linear regression lower deviation line (red line) and both indicators intersect with a Djinn prediction date a buy is triggered.
This trading strategy works on daily, weekly and Monthly Djinn Predictive charts.
This is not trading advice. Trade at your own risk.